Abstract
Introduction
Distress intolerance (DI), one’s perceived or behavioral incapacity to withstand distress, is implicated in psychopathology and smoking. This study evaluated the effect of DI on smoking reinforcement in the context of a carbon dioxide (CO2) biological challenge.
Methods
Adult daily smokers (n = 90; 48.9% female) were randomized to receive a single inhalation/breath of 35% CO2-enriched air (n = 45) or compressed room air (n = 45). Perceived DI was assessed before the challenge. Smoking reinforcement was examined via average post-challenge puff volume across puffs and at the puff-to-puff level.
Results
Higher DI was associated with an increased average puff volume (b = −4.7, p = .031). CO2 produced decreased average puff volume compared with room air (b = −7.7, p = .018). There was a DI* condition interaction (ƒ2 = 0.02), such that CO2 decreased average puff volume compared with room air in smokers with higher DI (b = −13.9, t = −3.06, p = .003), but not lower DI. At the puff-to-puff level, there was a significant interaction between DI, condition, and cubic time (b = 0.0003, p =. 037). Specifically, room air produced large initial puff volumes that decreased from puff to puff over the cigarette for high- and low-DI smokers. CO2 produced persistent flat volumes from puff to puff over the cigarette for higher DI smokers, whereas CO2 produced puff volumes like that of room air in lower DI smokers.
Discussion
Findings suggest DI heightens smoking reinforcement generally, and in the context of intense cardiorespiratory distress, is associated with stable and persistent smoking. DI is a promising therapeutic target that, if addressed through psychological intervention, may improve cessation outcomes by decreasing smoking reinforcement.
Implications
This study contributes to our understanding of the relationship between DI and smoking reinforcement, via examining these processes in response to acute cardiorespiratory distress. Specifically, we found that smokers who are less tolerant of distress, as opposed to those who are more tolerant, evince a decrease in average puff volume, and consistently low puff-to-puff volume, in response to a biological stressor. These findings suggest that smokers high in DI alter smoking behavior following acute cardiorespiratory distress, perhaps to reduce overstimulation, yet also persist in smoking in a manner that suggests an inability to achieve satiation.
Introduction
Distress intolerance (DI), an individual’s perception of or behavioral incapacity to withstand negative emotional or physical distress states,1 is an etiological and maintenance factor underlying multiple psychological disorders (eg, anxiety disorders, posttraumatic stress disorder, and major depressive disorder) and disorders characterized in part by maladaptive externalizing behaviors (eg, borderline personality disorder, eating disorders, and substance use disorders).2 Indeed, DI is implicated in the maintenance of cigarette smoking3,4 and is thought to underlie the comorbidity of psychological disorders and smoking.5 Theoretically, individuals with higher levels of DI may be more apt to avoid or engage in emotion-focused coping behaviors in response to internal distress cues.3,4 Higher DI is related to beliefs that smoking can aid in relieving negative affect6 and the tendency to smoke to alleviate negative affect.7 Moreover, in the context of acute abstinence-induced distress, higher levels of DI heighten smokers’ emotional reactivity to aversive interoceptive cues,8–10 which may exacerbate smoking-specific distress (eg, craving, withdrawal severity)11,12 and increase risk of smoking lapse13 and relapse.3,14,15 Thus, DI may serve to negatively reinforce smoking via the temporary amelioration of aversive states.16 For these reasons, DI has been identified as a promising therapeutic target in smoking cessation interventions17,18 and may be particularly relevant to smokers with comorbid psychological symptoms or disorders, given reductions in DI can improve mental health.19–22
It has been posited that through repeated pairing of smoking with acute distress states, smokers with higher DI may learn to associate cigarettes with pleasure (eg, relaxation, escape), which may enhance the incentive salience of cigarettes (ie, excessive motivation for a drug or “wanting”) and produce compulsive use behavior.23 Style of puffing behavior (ie, topography) has been conceptualized as a behavioral index of incentive motivation or a reinforcing value of smoking (ie, smoking reinforcement).24 DI has been described as vulnerability that is only “activated” in the context of a situational stressor or distress,12,13 and the extent to which DI is activated may depend on the specific type of stressor or form of distress (eg, nicotine withdrawal, negative mood, anxious arousal). For example, following a 12-hour period of nicotine deprivation, smokers with higher DI take larger average puff volumes during ad libitum smoking24 and take more puffs during a smoking task that elicited strong motivation to smoke and competing motivation to abstain.25 In contrast, perceived DI does not appear to be related to smoking reinforcement (ie, average puff volumes) in the context of neutral mood induction or in response to tasks that elicit negative mood, including viewing negative pictures, completing a challenging computer task, or preparing a social speech.24
Anxious arousal (physiological activation and bodily tension: eg, shortness of breath, dizziness, lightheadedness, trembling, shaking) is a primary and relatively unique feature of anxiety psychopathology,26,27 and is another distress state that can activate DI and create risk for persistent smoking.4,28 Biological challenge paradigms can be used to provide a reliable manipulation of acute physiological sensations associated with anxious arousal and panic attacks.29 One of the most widely used procedures is carbon dioxide (CO2)-enriched air breathing challenges,30 which can be dosed in several ways (eg, altering CO2 concentration or challenge length) to modify the duration and intensity of the physiological arousal.30 A single vital capacity inhalation of 35% CO2 gas mixture challenge involves one of the highest exposures but the briefest duration, and phenotypically produces abrupt physiological arousal characteristic of the onset of naturally occurring panic attacks.31 Using this approach, we previously found that 35% CO2-enriched air, compared with compressed room air, produced significant reductions in average puff volume during ad libitum smoking.32 The observed reduction in puff volumes following acute physiological arousal may reflect behavioral avoidance, due to high-intensity cardiopulmonary distress produced by CO2. Importantly, smokers with higher DI respond with greater fear to acute provocation of anxious arousal.8,12 Given that DI can “amplify” the negative subjective experience of distress, smokers with elevated DI may be hypersensitive to high-intensity anxious arousal, which may acutely dampen smoking behavior.
Therefore, this study tested the effect of DI on smoking reinforcement measured during ad libitum smoking following a biological challenge of 35% CO2 compared with room air. Smoking reinforcement was indexed by (1) average puff volume and (2) puff-level data to examine variability in puff volume over the course of a single cigarette following the biological challenge. On the basis of findings from the parent study,32 we hypothesized that the 35% CO2 biological challenge, compared with room air, would reduce average puff volume in smokers with higher DI because of hypersensitivity to the aversive nature of CO2 exposure. In addition, we hypothesized that smokers with higher DI compared to lower DI who were exposed to 35% CO2 would demonstrate more persistent puff volumes over the course of a cigarette, which is consistent with efforts to maximize and maintain nicotine exposure.33
Methods
Participants and Procedures
Participants (n = 90; 48.9% female) were adult nontreatment-seeking daily smokers recruited from a large urban city in a southern state in the United States to participate in an experimental study on smoking behavior.32 Inclusion criteria were as follows: (1) 18−65 years of age; (2) daily smoking for at least the past year; (3) smoking an average of at least 10 cigarettes per day; (4) smoking first cigarette of day within at least the first 30 minutes of waking34; and (5) stability of daily cigarette use (ie, had not decreased the number of daily cigarette use by more than half in the past 6 months). Exclusion criteria were as follows: (1) potentially contraindicated medical condition for completion of the biological challenge (eg, cardiovascular disease, chronic obstructive pulmonary disease); (2) limited mental competency and/or the inability to give informed, voluntary, written consent for participation; (3) being currently pregnant or nursing; (4) current (same-day) PRN use of psychotropic medication (eg, benzodiazepines); (5) current suicidal ideation and/or intent assessed via diagnostic assessment; (6) current (past year) non-nicotine substance use disorder or psychotic spectrum disorder; (7) current use of any pharmacotherapy or psychotherapy for smoking cessation; (8) insufficient command of the English language; and (9) self-reported low computer literacy due to the computerized nature of the study assessment and procedures. Participants were not excluded for regular daily use of psychotropic medications (ie, stable at least 3 months).
Baseline Assessment
Smoking history was assessed with the Smoking History Questionnaire,35 and tobacco dependence and characteristics of smokers’ usual cigarette brand were assessed by the Fagerström Test for Cigarette Dependence.34 A biochemical verification of smoking was conducted via expired carbon monoxide breath analysis to determine smoking recency. A clinical diagnostic assessment of past 12-month psychopathology was completed per the Structured Clinical Interview for DSM-IV-TR Disorders, Non-Patient Version36 to assess exclusion criteria. Participants then completed an ad libitum outdoor smoking trial at a standardized point during the baseline assessment using their own cigarette brand. Next, participants returned inside the laboratory for an adaptation period, during which they completed approximately 60 minutes of self-report assessments (including assessment of DI), which were broken up by two scheduled snack and water breaks (no smoking or caffeine was permitted). The adaptation period was designed to permit the effects of the nicotine to wear off and allow for smoking urges or withdrawal to acutely increase37 before the experimental manipulation. As expected, smoking urges per the Questionnaire of Smoking Urges-Brief38 significantly increased during the adaptation period (Mchange = 259.0, t = 9.38, df = 89, p < .001), which was a large sized-effect (d = 0.99).
Experimental Phase
Participants were then randomized to one of two experimental conditions (35% CO2-enriched air or compressed normal room air) using a computerized randomizer, designed to stratify condition assignment to be equivalent by sex. The participant and research assistant were blinded to experimental condition, and the biological challenge was administered by a separate unblinded researcher. The biological challenge task was a single vital capacity breath of CO2-enriched air mixture or compressed room air. Complete experimental procedures are reported in the original study.32 Briefly, participants were fitted with a respiration band, heart rate monitor, and mask that permitted only mouth breathing. Participants were then informed of the challenge procedures and shown a computerized instructional presentation that informed them how to complete two vital capacity breaths and then practiced and followed-along with the instructional prompt. The first vital capacity inhalation was used to clear air from the lungs (on forceful exhale) to prepare for the second vital capacity inhalation (with the manipulated air on randomization). This two-breath combination was completed twice. The first set was used to estimate the vital breath capacity of the participant; the second set for the actual manipulation. Cross-verification of the inhalation volume between the first and second set of breaths was checked for instructional adherence. After practice procedures, a 3-minute neutral adaptation period was observed, after which the biological challenge task was completed. Immediately following the inhalation, a 2-minute recovery period of normal breathing was observed. The manipulation check indicated that CO2-enriched air (compared with room air) produced significantly larger increases in subjective distress, panic attack symptoms, physiological arousal (heart rate, respiration rate), and peak expired end-tidal partial pressure CO2 (medium-to-large effects).32 After completion of the biological challenge, participants completed a second outdoor ad libitum smoking trial. Finally, participants were provided compensation ($50) and debriefed regarding the nature of the study and manipulation condition.
Measures
The Distress Tolerance Scale (DTS)39 is a self-report assessment of one’s perceived ability to experience and endure negative emotional distress states. The 14-item version of the DTS was used, which has been validated in community-recruited cigarette smokers.40 Items are answered on five-point Likert-type scales ranging from (1) strongly agree to (5) strongly disagree. Items are summed, and a mean score is computed; possible range is 1–5, with higher scores reflecting greater tolerance for distress (lower DI). The DTS items have good psychometric properties, including high internal consistency and appropriate convergence with other self-report ratings of affective distress and regulation,39 including in smoking samples.40 In the current sample, item internal consistency was high (Cronbach’s α = .937).
Smoking reinforcement was assessed before and after the biological challenge during outdoor smoking trials. Participants were told they could have a “smoke break” to smoke one cigarette using the portable Clinical Research Support System (CReSS device; Plowshare Technologies, Borgwaldt KC, Inc, Richmond, VA). Participants were oriented to the CReSS device and shown how to use it. The CReSS device has been validated for outdoor use and increases ecological validity.41 A research assistant accompanied participants outdoors alongside the laboratory for the smoking trial. Participants were instructed to smoke as usual, to avoid distractions while smoking (ie, do not talk to bystanders, use electronic devices), and were given as much time as desired to smoke a single cigarette. Puff topography data were downloaded from the CReSS device after smoking trials. The CReSS device has a sterilized flow meter mouthpiece that is connected to a pressure transducer, which converts pressure into a digital signal that is sampled at 1000 Hz. CReSS computer software transforms the signal to a flow rate (mL/s), from which puff topography data are computed. The reliability and acceptability of use of the portable CReSS device is well documented42,43 and the CReSS device is recommended over direct observation.42 Consistent with prior studies,24 puff volume (milliliter of smoke taken in during each puff) was used to index smoking reinforcement.
Data Analytic Procedures
Analyses were conducted using Stata v. 14. Smoking reinforcement was examined in two ways: (1) average puff volume and (2) change in puff volumes over smoking trial. In the first model, a linear regression model was constructed to test the main effects of condition and DTS, and the condition × DTS interaction on average puff volume post-challenge. In the second, multilevel modeling was used to examine the main and interactive effects of condition and DTS on changes in puff volume over number of puffs. Here, puff number was conceptualized as “time.” Thus, the multilevel modeling tested involved three primary predictors (condition, DTS, and time) and all interaction terms. The intraclass correlation values for puff-level volumes were above the conservative recommended value of .10 (intraclass correlation = .50, 95% CI = 0.42% to 0.58%). Linear, quadratic, cubic, and hyperbolic effects of time were modeled, and model fit was examined using Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Time (puff number) was mean centered to prevent multicollinearity when using higher-order polynomials.44 Random intercepts and slopes were included in all models. Huber-White robust sandwich estimators were used to adjust for heteroskedasticity in the error terms, and an unstructured covariance matrix was specified to allow for each covariance to be uniquely estimated.45
Model Building
Average puff volume (during smoking trial 1) was entered as a covarying factor to examine changes in puff volume resulting from the biological challenge. Experimental condition was dummy coded (0 = room air, 1 = CO2). Participant sex (coded 0 = male, 1 = female) was significantly negatively correlated with average puff volume during smoking trial 1 (r = .25, p = .016) and smoking trial 2 (r = −.22, p = .036); thus, sex was entered as a model covariate. Age, race, body mass index, level of cigarette dependence, cigarettes per day, menthol cigarette use, or smoking recency (expired carbon monoxide parts per million from breath analysis) were not associated with average puff volume during either smoking trial and were therefore not modeled as covariates. In addition, menthol use and race were not related to DTS. Continuous variables were mean centered before model entry. Significance was determined based on p value less than .05.
Data Cleaning
Raw puff-level smoking topography data were examined for range and outliers. Mean and standard deviation are reported as mean ± SD. The observed range of puffs during ad libitum smoking ranged from 7 to 43 (smoking trial 1; 21.3 ± 7.56) and 5 to 43 (smoking trial 2; 21.8 ± 8.92). Because of the small number of datapoints with at least 40 puffs (0.4% smoking trial 1, 1.0% smoking trial 2), those datapoints were dropped from analyses to maintain shape of the data distribution. Outlying values were identified using standard scores, with a criterion of z = 3.5 to retain maximum data.46 A small number of outlier values were detected (2.1% smoking trial 1; 1.3% smoking trial 2). The outliers were determined to be legitimate high-magnitude values and were recoded as one unit higher than the next lowest nonoutlying value.46
Results
Participants (n = 90; 48.9% female) were 43.6 ± 9.7 years old and self-reported race as primarily black or African American (61.1%) and white (32.2%). Approximately half completed at least part of college (54.4%), and employment status was primarily reported as full- or part-time (45.6%) and unemployed (35.6%). The sample reported smoking an average of 15.8 ± 5.9 cigarettes per day in the 7 days before the laboratory visit, and scores on the Fagerström Test for Cigarette Dependence were 4.8 ± 1.4, reflecting moderate levels of tobacco dependence. Average expired carbon monoxide levels at baseline were 24.0 ± 10.9 ppm. Slightly more than half of the sample reported smoking menthol cigarettes (58.9%). In terms of past 12-month psychological disorders, 33.3% of the sample met criteria for a DSM-IV defined Axis I disorder (of which, 46.7% had more than one diagnosis; range 1–4). For complete descriptive information on the sample, see the parent study.32 On average, DTS scores were 3.3 ± 1.0 (observed range 1.2–5.0).
Half of the sample (n = 45; 50.0%) was randomized to 35% CO2 and the other half was randomized to room air. In the parent study, there were no significant demographic or smoking characteristics by experimental condition.
Average Smoking Reinforcement
Results from the multiple regression predicting post-challenge change in average puff volume are displayed in Table 1. The overall model was significant (F(5,84) = 20.68, p < .001; R2 = .55). In addition, there was a significant main effect of DTS on puff volume, such that higher DI was associated with significantly greater increases in puff volume following the biological challenge regardless of condition (b = −4.7, p = .031). There was also a small-sized DTS × condition interaction at a trend level (b = 5.6, p = .060; ƒ2 = 0.02).
Table 1.
Regression Model Predicting Changes in Average Puff Volume
| Variable | b | SE | t | p |
|---|---|---|---|---|
| Sex (female = 1) | −3.1 | 3.4 | −0.93 | .355 |
| Puff volume (Pre-Challenge) | 0.5 | 0.1 | 9.20 | <.001 |
| Condition (CO2 = 1) | −7.7 | 3.2 | −2.40 | .018 |
| DTS | −4.7 | 2.2 | −2.19 | .031 |
| Condition × DTS | −0.01 | 0.01 | −2.18 | .060 |
Continuous variables were mean centered. CO2 = carbon dioxide; DTS = Distress Tolerance Scale.
Figure 1 illustrates the model-based estimations of the “simple slopes” (regression lines), showing the relationship between condition and post-challenge puff volume for participants at two levels of DI ±/− 1 SD from the mean of DTS. The form of the interaction revealed that 35% CO2 produced significantly larger reductions in puff volume compared to room air in smokers with higher DI (−1 SD DTS; b = -13.9, t = −3.06, p = .003), but not for those with lower DI (+1 SD DTS; b = −1.5, t = −0.33, p = .740). The Johnson−Neyman technique was used (per recommendations)47 to statistically identify points in the range of the continuous moderator variable (DTS) where the effect of the predictor on the criterion variable transitions from being statistically significant to nonsignificant. The Johnson−Neyman technique revealed that the effect of 35% CO2 on reduced puff volume was significant for smokers with DTS scores less than or equal to 3.53, which included 54.4% of the sample; the conditional effect became stronger as DTS scores decreased.
Figure 1.
Interaction between distress intolerance (DI) and biological challenge on average puff volume. High DI (−1 SD on the Distress Tolerance Scale [DTS]) and low DI (+1 SD on the DTS).
Puff Level Smoking Reinforcement
Results from the multilevel modeling are presented in Table 2. Comparison of model fit indices indicated that a model with a cubic effect of time best fit the data (lowest AIC and BIC values: linear time [AIC = 17254.1, BIC = 17332.1]; quadratic time [AIC = 17236.8, BIC = 17337.1]; cubic time [AIC = 17217.7, BIC = 17320.3]; hyperbolic time [AIC = 17323.1, BIC = 17378.8]). Results indicated that there was a main effect of cubic time (b = 0.0035, p = .005). Yet, neither the DTS × cubic time interaction (p = .247) and the condition × cubic time interaction (p = .317) were significant. However, the cubic time × condition × DTS interaction was significant (b = 0.0003, p = .037). See Figure 2. The form of the interaction indicated that 35% CO2 produced persistent (ie, flat) puff volumes over the course of smoking in smokers with higher DI and produced initial increases in puffs volumes, which gradually decreased over the course of smoking in smokers with lower DI. In contrast, room air produced a similar pattern of puff volumes to that observed in smokers lower in DI following CO2 for smokers with higher and lower DI, except for an additional increase in puff volumes in smokers with higher DI toward the end of the ad libitum session.
Table 2.
Results From Puff-Level Analyses
| Variable | b | 95% CI | SE | z | p | |
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Linear time | −0.8680 | −1.6771 | −0.0588 | 0.4128 | −2.10 | .036 |
| Quadratic time | 0.0053 | −0.0240 | 0.0346 | 0.0149 | 0.36 | .722 |
| Cubic time | 0.0035 | 0.0011 | 0.0060 | 0.0013 | 2.80 | .005 |
| Sex (1 = female) | −3.0417 | −9.4358 | 3.3524 | 3.2623 | −0.93 | .351 |
| Average puff volume (Pre-Challenge) | 0.5192 | 0.3023 | 0.7360 | 0.1106 | 4.69 | <.001 |
| Condition (1 = CO2) | −5.1345 | −17.1009 | 6.8319 | 6.1054 | −0.84 | .400 |
| DTS | −2.0256 | −10.3138 | 6.2625 | 4.2287 | −0.48 | .632 |
| Condition × DTS | 1.2232 | −8.5251 | 10.9714 | 4.9737 | 0.25 | .806 |
| Linear time × condition | 0.1700 | −0.9334 | 1.2733 | 0.5629 | 0.30 | .763 |
| Linear time × DTS | 0.2278 | −0.4294 | 0.8850 | 0.3353 | 0.68 | .497 |
| Linear time × condition × DTS | −1.0493 | −1.9454 | −0.1532 | 0.4572 | −2.30 | .022 |
| Quadratic time × condition | −0.0207 | −0.0576 | 0.0162 | 0.0188 | −1.10 | .271 |
| Quadratic time × DTS | −0.0193 | −0.0451 | 0.0065 | 0.0132 | −1.47 | .142 |
| Quadratic time × condition × DTS | 0.0096 | −0.0309 | 0.0501 | 0.0207 | 0.46 | .642 |
| Cubic time × condition | −0.0016 | −0.0048 | 0.0015 | 0.0016 | −1.00 | .317 |
| Cubic time × DTS | −0.0014 | −0.0037 | 0.0009 | 0.0012 | −1.16 | .247 |
| Cubic time × condition × DTS | 0.0034 | 0.0002 | 0.0066 | 0.0016 | 2.09 | .037 |
Models with statistically significant effects are presented in bold for ease in viewing. Continuous variables were mean centered. CO2 = carbon dioxide; DTS = Distress Tolerance Scale.
Figure 2.
Interaction between distress intolerance (DI) and biological challenge on puff volume trajectory. High DI (−1 SD on the Distress Tolerance Scale [DTS]) and low DI (+1 SD on the DTS).
Discussion
The study provides a novel laboratory model of the relation between DI and smoking reinforcement via comparison of smoking behavior following acute anxious arousal (ie, 35% CO2) versus a control (ie, no stress) biological challenge. We aimed to extend our previous finding that 35% CO2 decreases smoking reinforcement compared with room air,32 by considering the role of perceived DI.
We found that regardless of condition, DI is associated with increases in average puff volume during ad libitum smoking following the biological challenge. Given that DI is associated with reliance on “quick-fix” coping strategies in the face of emotional and physical distress,48,49 larger puff volumes in smokers may demarcate the tendency to smoke to escape, avoid, or cope with distressing states.24 According to negative reinforcement models, individuals learn to associate rapid alleviation of distress with smoking, which may contribute to the maintenance of the reinforcing value of cigarettes. Interestingly, compared with room air, CO2 decreased puff volume in smokers with higher DI, but not for those with lower DI. Thus, the main effect of DI and interactive effects operate in different ways: DI contributes to increased puff volumes on average, but in the context of acute anxious arousal, DI contributes to attenuated puffing behavior. Given that smokers with elevated DI are hypersensitive to acute anxious arousal produced by CO2 (eg, dry mouth, lightheadedness, racing heart, and suffocation feelings),12 these smokers may experience smoke inhalation and the activating effects of nicotine to be particularly aversive following CO2 exposure and in turn, may compensate by taking smaller puffs to avoid further provocation of distress.32 Here, smaller puff volumes reflect attempts to avoid additional cardiopulmonary distress, which can maintain reliance on cigarettes via negative reinforcement learning. In contrast, in the presence of lower-intensity arousal (ie, room air biological challenge), smokers with elevated DI may be more likely to rely on cigarettes to downregulate mild levels of anxious arousal, thus evidence greater puff volumes that negatively reinforce continued smoking. These findings offer increased specificity to models of negative reinforcement smoking motivation in the context of anxious arousal, specifically,30 relative to other situational states such as nicotine withdrawal or negative mood states.24,25
We also conducted a fine-grained analysis to examine the association between DI and biological challenge response at the puff-to-puff level. Puff volumes over the course of ad libitum smoking differed as a function of DI and CO2 exposure. Regardless of level of DI, inhalation of room air produced large initial puff volumes at the beginning of the cigarette, which gradually declined over the ad libitum session. This is a typical pattern of puffing that is thought to reflect initial nicotine loading (ie, early large puff volumes) and subsequent satiation evidenced by decreasing puff volume.50 Smokers with higher DI evidenced increased puff volumes toward the end of ad libitum smoking, suggesting that they may place higher value on the final puffs of a cigarette and use these puffs as a final opportunity for distress relief or coping. In contrast, 35% CO2 produced a persistently “flat” shape of puff volumes over the course of the cigarette in smokers with higher DI. Thus, for smokers with higher perceived DI, intense cardiorespiratory arousal may interfere with the ability to achieve satiation, possibly because of the absence of initial nicotine loading while smoking. Consistent (ie, flat) puff volumes during ad libitum smoking have previously been documented among smokers with a history of panic attacks and also may reflect a modified smoking pattern aimed at avoiding sudden surges in arousal, including nicotine-induced arousal.33 Importantly, 35% CO2 produced persistent and stable puff volumes only for smokers with higher DI, but not for those with lower DI. This finding underscores the importance of considering one’s perception of his or her ability to withstand distress in the context of better understanding emotional vulnerabilities for smoking.3,51
There are several limitations to this study. First, although a CO2 biological challenge is a common anxiety-induction procedure that reliably induces anxious arousal,30 the 35% CO2 dose produces an intense surge of physiological arousal, as seen in panic attacks.31 Thus, these findings may not necessarily generalize to work focused on DI and trait anxiety or lower-intensity anxious states and should not be viewed as necessarily comparable to work specific to negative mood–induced smoking.24 Second, perceived DI was indexed by the DTS, which taps one’s perceived (in)ability to tolerate psychological distress states. We did not consider how one’s perceived inability to tolerate physiological distress or other specific emotional states (eg, frustration, uncertainty) may influence smoking reinforcement. Third, we did not examine one’s actual ability to withstand distress in terms of smoking reinforcement (ie, behavioral DI), which may offer unique information about emotional vulnerability and smoking.51 However, prior work has failed to find an association between behavioral indices of DI and smoking reinforcement,52 potentially because behavioral DI is influenced by certain states or conditions,53,54 suggesting it may have state like vulnerability and influence. Fourth, we conceptualized puff topography as a behavioral index of smoking reinforcement,24,32 although puff volume can be influenced by individual difference factors not related to smoking intensity. We evaluated numerous individual factors in relation to puff volume and adjusted for those that were relevant (ie, sex). Nevertheless, we cannot rule out the possibility that additional unmeasured factors may influence puff topography. Fifth, the parent study was powered to detect medium-sized interactions, and although consistent with prior work,24 findings here evidenced small-to-medium interaction effects. Finally, participants were recruited from a southern state in the United States, and the resulting sample comprised primarily smokers who were black or African American (61.1%) with low socioeconomic status, and high prevalence of psychopathology. The prevalence of menthol cigarette use was also high (58.9%), and nearly all menthol users were identified as black or African American (89.1%). Although our sample reflects a subgroup of the population that is at particularly high risk for tobacco-related disease,55 it may also limit generalizability of findings. Although neither race nor menthol use was related to DI or puff volume in this study, more work is needed in this arena, given the significant dearth of existing studies pertaining to DI56 and equivocal results in puff topography.57–59
This study presents novel laboratory evidence that identifies the impact of perceived DI, an identified therapeutic target (ie, mechanism), on smoking reinforcement. Specifically, smokers with higher DI appear to alter smoking behavior following acute cardiorespiratory distress, perhaps to reduce overstimulation, yet also persist in smoking in a manner that suggests an inability to achieve satiation. This type of research approach is aligned with research initiatives in precision medicine,60 the National Institutes of Health’s Science of Behavior Change,61 and experimental therapeutics,62 which propel systematic identification of a potential mechanism that can be targeted in tailored treatment to improve physical and mental health outcomes. Indeed, the current findings have direct implications for the development of well-specified smoking cessation interventions for smokers who are at elevated risk for psychopathology (high DI) or with comorbid psychological symptoms or disorders.63 Cognitive and behavioral interventions can be used to increase awareness and tolerance,64 which may include uncomfortable physical distress states (ie, interoceptive exposure) and negative emotional distress states. In fact, reductions in perceived DI before a smoking cessation attempt produce improved short-term smoking abstinence.17,18 Thus, one’s perception of his or her ability to tolerate distress may be an important precessation treatment target to aid in decreasing the reinforcing value of smoking, especially distress-motivated smoking. When planning exposure-based interventions for smokers, it may be particularly important to tailor the intensity and type of distress induction to understand the unique influence that various distress states have on smoking reinforcement for each individual. Smokers may also benefit from receiving personalized feedback about how they smoke in response to certain distress states to help identify internal distress states that enhance the incentive salience of cigarettes.
Funding
This work was funded by a predoctoral National Research Service Award (F31-DA035564) awarded to SGF. The research described in this article was also supported in part by a grant to SGF from the American Psychological Association. SGF was supported by a training grant from the National Heart, Lung, and Blood Institute (T32-HL076134-11). Manuscript preparation was supported in part by a grant from the National Institute on Drug Abuse (K01-DA039311) to ERA. The funding sources had no other role other than financial support.
Declaration of Interests
The authors declare that there is no conflict of interest.
References
- 1. Zvolensky MJ, Leyro TM, Bernstein A, Vujanovic AA. Historical perspectives, theory, and measurement of distress tolerance. In: Zvolensky MJ, Bernstein A, Vujanovic AA, eds. Distress Tolerance: Theory, Research, and Clinical Applications. New York, NY: Guilford; 2010. [Google Scholar]
- 2. Leyro TM, Zvolensky MJ, Bernstein A. Distress tolerance and psychopathological symptoms and disorders: a review of the empirical literature among adults. Psychol Bull. 2010;136(4):576–600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Brown RA, Lejuez CW, Kahler CW, Strong DR, Zvolensky MJ. Distress tolerance and early smoking lapse. Clin Psychol Rev. 2005;25(6): 713–733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull. 2015;141(1):176–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Zvolensky MJ, Farris SG, Leventhal AM, Schmidt NB. Anxiety sensitivity mediates relations between emotional disorders and smoking. Psychol Addict Behav. 2014;28(3):912–920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Shadur JM, Ninnemann AL, Lim A, Lejuez CW, MacPherson L. The prospective relationship between distress tolerance and cigarette smoking expectancies in adolescence. Psychol Addict Behav. 2017;31(5):625–635. [DOI] [PubMed] [Google Scholar]
- 7. Trujillo MA, Khoddam R, Greenberg JB, et al. Distress tolerance as a correlate of tobacco dependence and motivation: incremental relations over and above anxiety and depressive symptoms. Behav Med. 2017;43(2):120–128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Marshall EC, Zvolensky MJ, Vujanovic AA, Gregor K, Gibson LE, Leyro TM. Panic reactivity to voluntary hyperventilation challenge predicts distress tolerance to bodily sensations among daily cigarette smokers. Exp Clin Psychopharmacol. 2008;16(4):313–321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Zvolensky MJ, Feldner MT, Leen-Feldner EW, Gibson LE, Abrams K, Gregor K. Acute nicotine withdrawal symptoms and anxious responding to bodily sensations: a test of incremental predictive validity among young adult regular smokers. Behav Res Ther. 2005;43(12): 1683–1700. [DOI] [PubMed] [Google Scholar]
- 10. Abrams K, Leger K, Schlosser L, Merrill A, Bresslour M, Jalan A. Nicotine withdrawal exacerbates fear reactivity to CO₂-induced bodily sensations among smokers. Nicotine Tob Res. 2011;13(11):1052–1058. [DOI] [PubMed] [Google Scholar]
- 11. Volz AR, Dennis PA, Dennis MF, Calhoun PS, Wilson SM, Beckham JC. The role of daily hassles and distress tolerance in predicting cigarette craving during a quit attempt. Nicotine Tob Res. 2014;16(6):872–875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Farris SG, Zvolensky MJ, Otto MW, Leyro TM. The role of distress intolerance for panic and nicotine withdrawal symptoms during a biological challenge. J Psychopharmacol. 2015;29(7):783–791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Abrantes AM, Strong DR, Lejuez CW, et al. The role of negative affect in risk for early lapse among low distress tolerance smokers. Addict Behav. 2008;33(11):1394–1401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Rohsenow DJ, Tidey JW, Kahler CW, Martin RA, Colby SM, Sirota AD. Intolerance for withdrawal discomfort and motivation predict voucher-based smoking treatment outcomes for smokers with substance use disorders. Addict Behav. 2015;43:18–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Kahler CW, McHugh RK, Metrik J, Spillane NS, Rohsenow DJ. Breath holding duration and self-reported smoking abstinence intolerance as predictors of smoking lapse behavior in a laboratory analog task. Nicotine Tob Res. 2013;15(6):1151–1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. McCarthy DE, Curtin JJ, Piper ME, Baker TB. Negative reinforcement: possible clinical implications of an integrative model. In: Kassel JD, ed. Substance Abuse and Emotion. Washington: American Psychological Association; 2010:15–42. [Google Scholar]
- 17. Brown RA, Palm Reed KM, Bloom EL, et al. A randomized controlled trial of distress tolerance treatment for smoking cessation. Psychol Addict Behav. 2018;32(4):389–400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Farris SG, Leyro TM, Allan NP, Øverup CS, Schmidt NB, Zvolensky MJ. Distress intolerance during smoking cessation treatment. Behav Res Ther. 2016;85:33–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Boffa JW, Short NA, Gibby BA, Stentz LA, Schmidt NB. Distress tolerance as a mechanism of PTSD symptom change: evidence for mediation in a treatment-seeking sample. Psychiatry Res. 2018;267:400–408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Williams AD, Thompson J, Andrews G. The impact of psychological distress tolerance in the treatment of depression. Behav Res Ther. 2013;51(8):469–475. [DOI] [PubMed] [Google Scholar]
- 21. Linehan MM, Heard HL, Armstrong HE. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch Gen Psychiatry. 1993;50(12):971–974. [DOI] [PubMed] [Google Scholar]
- 22. Hayes SC, Strosahl KD, Wilson KG.. Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change. New York, NY: Guilford Press; 1999. [Google Scholar]
- 23. Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction. 2000;95(suppl 2):S91–S117. [DOI] [PubMed] [Google Scholar]
- 24. Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA, Sayette MA. Differences in negative mood-induced smoking reinforcement due to distress tolerance, anxiety sensitivity, and depression history. Psychopharmacology (Berl). 2010;210(1):25–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Bold KW, Yoon H, Chapman GB, McCarthy DE. Factors predicting smoking in a laboratory-based smoking-choice task. Exp Clin Psychopharmacol. 2013;21(2):133–143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Watson D, Clark LA, Weber K, Assenheimer JS, Strauss ME, McCormick RA. Testing a tripartite model: II. Exploring the symptom structure of anxiety and depression in student, adult, and patient samples. J Abnorm Psychol. 1995;104(1):15–25. [DOI] [PubMed] [Google Scholar]
- 27. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol. 1991;100(3):316–336. [DOI] [PubMed] [Google Scholar]
- 28. Zvolensky MJ, Bernstein A. Cigarette smoking and panic psychopathology. Curr Dir Psychol Sci. 2005;14(6):301–305. [Google Scholar]
- 29. Zvolensky MJ, Eifert GH. A review of psychological factors/processes affecting anxious responding during voluntary hyperventilation and inhalations of carbon dioxide-enriched air. Clin Psychol Rev. 2001;21(3):375–400. [DOI] [PubMed] [Google Scholar]
- 30. Abrams K, Schruers K, Cosci F, Sawtell S. Biological challenge procedures used to study co-occurring nicotine dependence and panic disorder. Addict Behav. 2008;33(11):1463–1469. [DOI] [PubMed] [Google Scholar]
- 31. Vickers K, Jafarpour S, Mofidi A, Rafat B, Woznica A. The 35% carbon dioxide test in stress and panic research: overview of effects and integration of findings. Clin Psychol Rev. 2012;32(3):153–164. [DOI] [PubMed] [Google Scholar]
- 32. Farris SG, Zvolensky MJ. An experimental test of the effect of acute anxious arousal and anxiety sensitivity on negative reinforcement smoking. J Psychopharmacol. 2016;30(7):641–653. [DOI] [PubMed] [Google Scholar]
- 33. Farris SG, Brown LA, Goodwin RD, Zvolensky MJ. Panic attack history and smoking topography. Drug Alcohol Depend. 2017;171:84–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Fagerström KO. Determinants of tobacco use and renaming the FTND to the Fagerström test for cigarette dependence. Nicotine Tob Res. 2012;14(1):75–78. [DOI] [PubMed] [Google Scholar]
- 35. Brown RA, Lejuez CW, Kahler CW, Strong DR. Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol. 2002;111(1):180–185. [PubMed] [Google Scholar]
- 36. First MB, Spitzer RL, Gibbon M, Williams JB.. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition. New York, NY: Biometrics Research, New York State Psychiatric Insititue; 2007. [Google Scholar]
- 37. Hendricks PS, Ditre JW, Drobes DJ, Brandon TH. The early time course of smoking withdrawal effects. Psychopharmacology (Berl). 2006;187(3):385–396. [DOI] [PubMed] [Google Scholar]
- 38. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3(1):7–16. [DOI] [PubMed] [Google Scholar]
- 39. Simons JS, Gaher RM. The distress tolerance scale: development and validation of a self-report measure. Motiv Emot. 2005;29(2):83–102. [Google Scholar]
- 40. Leyro TM, Bernstein A, Vujanovic AA, McLeish AC, Zvolensky MJ. Distress tolerance scale: a confirmatory factor analysis among daily cigarette smokers. J Psychopathol Behav Assess. 2011;33(1):47–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. June KM, Norton KJ, Rees VW, O’Connor RJ. Influence of measurement setting and home smoking policy on smoking topography. Addict Behav. 2012;37(1):42–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Blank MD, Disharoon S, Eissenberg T. Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation. Nicotine Tob Res. 2009;11(7):896–903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA. The reliability of puff topography and subjective responses during ad lib smoking of a single cigarette. Nicotine Tob Res. 2012;14(4):490–494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Aiken LS, West SG.. Multiple Regression: Testing and Interpreting Interactions. Thousand Oaks, CA: Sage Publications; 1991. [Google Scholar]
- 45. StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP; 2015. [Google Scholar]
- 46. Tabachnick BG, Fidell LS.. Using Multivariate Statistics. 4th ed. Boston, MA: Allyn & Bacon; 2000. [Google Scholar]
- 47. Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. New York, NY: Guilford Press; 2013. [Google Scholar]
- 48. Potter CM, Vujanovic AA, Marshall-Berenz EC, Bernstein A, Bonn-Miller MO. Posttraumatic stress and marijuana use coping motives: the mediating role of distress tolerance. J Anxiety Disord. 2011;25(3):437–443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. McHugh RK, Weiss RD, Cornelius M, Martel MO, Jamison RN, Edwards RR. Distress intolerance and prescription opioid misuse among patients with chronic pain. J Pain. 2016;17(7):806–814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Guyatt AR, Kirkham AJ, Baldry AG, Dixon M, Cumming G. How does puffing behavior alter during the smoking of a single cigarette?Pharmacol Biochem Behav. 1989;33(1):189–195. [DOI] [PubMed] [Google Scholar]
- 51. Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull. 2015;141(1):176–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Perkins KA, Giedgowd GE, Karelitz JL, Conklin CA, Lerman C. Smoking in response to negative mood in men versus women as a function of distress tolerance. Nicotine Tob Res. 2012;14(12):1418–1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Bernstein A, Trafton J, Ilgen M, Zvolensky MJ. An evaluation of the role of smoking context on a biobehavioral index of distress tolerance. Addict Behav. 2008;33(11):1409–1415. [DOI] [PubMed] [Google Scholar]
- 54. Farris SG, Metrik J. Acute effects of cannabis on breath-holding duration. Exp Clin Psychopharmacol. 2016;24(4):305–312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Center for Disease Control and Prevention. Racial/ethnic disparities and geographic differences in lung cancer incidence—38 states and the district of Columbia, 1998–2006. Morb Mortal Wkly Rep. 2010;59(44):1433–1438. [PubMed] [Google Scholar]
- 56. Dahne J, Stratton KJ, Brown R, Amstadter AB, Lejuez CW, MacPherson L. Race as a moderator of the relationship between distress tolerance and cigarette smoking. Subst Use Misuse. 2014;49(6):708–714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Watson CV, Richter P, de Castro BR, et al. Smoking behavior and exposure: results of a menthol cigarette cross-over study. Am J Health Behav. 2017;41(3):309–319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Ahijevych K, Garrett BE. Menthol pharmacology and its potential impact on cigarette smoking behavior. Nicotine Tob Res. 2004;6(suppl 1):S17–S28. [DOI] [PubMed] [Google Scholar]
- 59. Strasser AA, Ashare RL, Kaufman M, Tang KZ, Mesaros AC, Blair IA. The effect of menthol on cigarette smoking behaviors, biomarkers and subjective responses. Cancer Epidemiol Biomarkers Prev. 2013;22(3):382–389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Ma J, Rosas LG, Lv N. Precision lifestyle medicine: a new frontier in the science of behavior change and population health. Am J Prev Med. 2016;50(3):395–397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Riley WT. Behavioral and social sciences at the National Institutes of Health: methods, measures, and data infrastructures as a scientific priority. Health Psychol. 2017;36(1):5–7. [DOI] [PubMed] [Google Scholar]
- 62. Lewandowski KE, Ongur D, Keshavan MS. Development of novel behavioral interventions in an experimental therapeutics world: challenges, and directions for the future. Schizophr Res. 2018;192:6–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Zvolensky MJ, Garey L, Allan NP, et al. Effects of anxiety sensitivity reduction on smoking abstinence: an analysis from a panic prevention program. J Consult Clin Psychol. 2018;86(5):474–485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Bornovalova MA, Gratz KL, Daughters SB, Hunt ED, Lejuez CW. Initial RCT of a distress tolerance treatment for individuals with substance use disorders. Drug Alcohol Depend. 2012;122(1–2):70–76. [DOI] [PMC free article] [PubMed] [Google Scholar]


